Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kezar Life Sciences Inc (DE:2KZ0)
FRANKFURT:2KZ0
RESEARCH TOOLSreports
Holding DE:2KZ0?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | $ 7.00M | - |
| Gross Profit | - | - | - | $ 7.00M | - |
| EBIT | $ -21.15M | $ -21.26M | $ -31.86M | $ -22.71M | $ -23.92M |
| EBITDA | $ -19.31M | $ -21.00M | $ -31.58M | $ -24.14M | $ -25.43M |
| Net Income Common Stockholders | $ -21.55M | $ -21.66M | $ -32.26M | $ -23.10M | $ -24.31M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 164.18M | $ 179.80M | $ 201.37M | $ 218.21M | $ 236.59M |
| Total Assets | $ 179.92M | $ 199.13M | $ 221.24M | $ 249.33M | $ 263.38M |
| Total Debt | $ 17.61M | $ 18.29M | $ 18.93M | $ 19.55M | $ 20.15M |
| Net Debt | $ -146.57M | $ -161.51M | $ -182.44M | $ -198.65M | $ -216.44M |
| Total Liabilities | $ 29.24M | $ 30.01M | $ 33.66M | $ 33.33M | $ 31.10M |
| Stockholders Equity | $ 150.69M | $ 169.14M | $ 187.57M | $ 215.99M | $ 232.28M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -17.03M | $ -22.86M | $ -18.98M | $ -20.34M | $ -22.98M |
| Operating Cash Flow | $ -17.03M | $ -22.86M | $ -18.98M | $ -20.20M | $ -21.60M |
| Investing Cash Flow | $ 12.22M | $ 20.41M | $ 27.88M | $ 18.57M | $ 13.20M |
| Financing Cash Flow | $ 56.00K | - | $ 59.00K | $ 43.00K | $ 382.00K |